Table 2.
Results of cost-effectiveness analysis. Results of the base-case cost-effectiveness analysis and of variations of the price per examination of AB-MRI. All values reference a common baseline (XM)
| Strategy (cost per examination in US-$) | Cumulative discounted costs (US-$) | Incremental costs (US-$) | Cumulative discounted effects (QALYs) | Incremental effects (QALYs) | ICER (US-$/QALY) |
|---|---|---|---|---|---|
|
XM $ 102 |
8,718 | n/a | 19.22 | n/a | n/a |
|
DBT $ 214 |
8,815 | 97 | 19.22 | 0.005 | 19,785 |
| AB-MRI | |||||
| $ 314 | 9,779 | 1,062 | 19.25 | 0.037 | 28,458 |
| $ 300 | 9,644 | 927 | 19.25 | 0.037 | 24,840 |
| $ 280 | 9,452 | 734 | 19.25 | 0.037 | 19,671 |
| $ 260 | 9,259 | 541 | 19.25 | 0.037 | 14,501 |
| $ 240 | 9,066 | 348 | 19.25 | 0.037 | 9,332 |
| $ 220 | 8,873 | 155 | 19.25 | 0.037 | 4,163 |
| $ 200 | 8,680 | -38 | 19.25 | 0.037 | n/a |
|
FB-MRI $ 314 |
9,283 | 565 | 19.26 | 0.038 | 15,018 |
ICER, incremental cost-effectiveness analysis; QALY, quality-adjusted life year; XM, x-ray mammography; DBT, digital breast tomosynthesis; AB-MRI, abbreviated breast magnetic resonance imaging; FB-MRI, full protocol breast magnetic resonance mammography